Citing increasing drug costs and a shift in consumer demand away from traditional pharmacies, Rutgers University in New Brunswick, N.J., will shut down all three of its on-campus pharmacies later this year, according to the Daily Targum.

Health insurer Cigna introduced a plan Sept. 5 to fully cover the cost of expensive gene therapy treatments for patients. 

Several pharma companies, distributors and pharmacies must face a federal court jury next month in response to claims that they conspired to commit "unlawful acts"in the marketing, delivering and selling of opioids, according to Bloomberg.

The pharmaceutical industry is now the most poorly regarded industry in the U.S., claiming last place in Gallup's latest poll that asks American's for their views on 25 industries.

States with more comprehensive prescription drug monitoring programs saw hospital use and opioid prescription rates decline, according to a study published Sept. 3 in Health Affairs. 

With drug prices increasing five times the rate of inflation, CVS Health is working to make prescriptions more affordable by continuously removing drugs with hyperinflated prices from its formulary.

As Hurricane Dorian continues its path up the East Coast, both big and small businesses have to make a decision on whether or not to stay open or close. The decision is particularly hard for those in the healthcare profession,…

Bayer has hired Marianne De Backer, a former Johnson & Johnson executive, to manage its acquisitions and licensing deals, according to Endpoints News. 

Allergan agreed to pay $5 million to settle allegations that it helped fuel the national opioid crisis, according to The Wall Street Journal. The settlement allows Allergan to sidestep a potentially damaging opioid trial set to begin next month.

Novartis launched 17 drugs between 2009 to 2018, making it the top performer, according to data cited by STAT.